34271 |
Oncology |
Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, ... |
CANCER RES TREAT 2017 10.4143/crt.2016.282 |
최철훈 |
2017 |
34270 |
Reproductive Biology |
Interval between secondary cytoreductive surgery and adjuvant chemothe... |
J OVARIAN RES 2019 10.1186/s13048-019-0602-5 |
최철훈 |
2019 |
34269 |
Obstetrics & Gynecology |
Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Co... |
GYNECOL OBSTET INVES 2018 10.1159/000475817 |
최철훈 |
2018 |
34268 |
Oncology |
Development and Validation of Ovarian Symptom Index-18 and Neurotoxcit... |
CANCER RES TREAT 2019 10.4143/crt.2017.361 |
최철훈 |
2019 |
34267 |
Oncology; Obstetrics & Gynecology |
Clinical outcomes of patients with clear cell and endometrioid ovarian... |
J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18 |
최철훈 |
2018 |
34266 |
Oncology; Obstetrics & Gynecology |
A phase II study of neoadjuvant chemotherapy plus durvalumab and treme... |
J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112 |
최철훈 |
2019 |
34265 |
Oncology |
An umbrella study of biomarker-driven targeted therapy in patients wit... |
JPN J CLIN ONCOL 2019 10.1093/jjco/hyz085 |
최철훈 |
2019 |
34264 |
Multidisciplinary Sciences |
Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human... |
SCI REP-UK 2019 10.1038/s41598-019-51959-3 |
최철훈 |
2019 |
34263 |
Oncology; Obstetrics & Gynecology |
Three-Year Recurrence-Free Survival in Patients With a Very Low Risk o... |
INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001270 |
최철훈 |
2018 |
34262 |
Oncology |
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-l... |
CANCER RES 2017 10.1158/0008-5472.CAN-17-0072 |
최철훈 |
2017 |